Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 20 articles: HTML format

Single Articles

August 2023
1. 
   Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
   N Engl J Med. 2023;389:772.
   PubMed    
   
   
   June 2023
2. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
   Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
   N Engl J Med. 2023;388:2444-2455.
   PubMed     Abstract available
   
   
   May 2023
3. ABREU MT
   JAK1 Inhibition to Treat Crohn's Disease.
   N Engl J Med. 2023;388:2005-2009.
   PubMed    
   
   
   
4. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
   Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
   N Engl J Med. 2023;388:1966-1980.
   PubMed     Abstract available
   
   
   March 2023
5. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
   Vedolizumab for the Treatment of Chronic Pouchitis.
   N Engl J Med. 2023;388:1191-1200.
   PubMed     Abstract available
   
   
   April 2022
6. KOTHARI R, Vashisht D
   Knife-Cut Ulcers in Crohn's Disease.
   N Engl J Med. 2022;386:e37.
   PubMed    
   
   
   January 2022
7. ZANGER K, Nimkin K, Israel EJ, Shih AR, et al
   Case 3-2022: A 14-Year-Old Boy with Fever, Joint Pain, and Abdominal Cramping.
   N Engl J Med. 2022;386:375-383.
   PubMed    
   
   
   
8. SANDBORN WJ, Danese S
   Ozanimod for Ulcerative Colitis. Reply.
   N Engl J Med. 2022;386:194-195.
   PubMed    
   
   
   
9. SENUSSI NH, Rakov N
   Ozanimod for Ulcerative Colitis.
   N Engl J Med. 2022;386:194.
   PubMed    
   
   
   
10. MACALUSO FS, Orlando A
    Ozanimod for Ulcerative Colitis.
    N Engl J Med. 2022;386:194.
    PubMed    
    
    
    November 2021
11. PETRUZZI M, Della Vella F
    Pyostomatitis Vegetans.
    N Engl J Med. 2021;385:e77.
    PubMed    
    
    
    September 2021
12. BAUMGART DC, Le Berre C
    Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease.
    N Engl J Med. 2021;385:1302-1315.
    PubMed    
    
    
    
13. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    PubMed     Abstract available
    
    
    August 2021
14. SCHETT G, McInnes IB, Neurath MF
    Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.
    N Engl J Med. 2021;385:628-639.
    PubMed    
    
    
    April 2021
15. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases. Reply.
    N Engl J Med. 2021;384:1378.
    PubMed    
    
    
    
16. MRAVEC B
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377-1378.
    PubMed    
    
    
    
17. GAFFNEY P, Gaffney R
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377.
    PubMed    
    
    
    
18. CHEN CJ, Hu H, Liao WT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1376-1377.
    PubMed    
    
    
    February 2021
19. THOMAS AS, Ma W, Wang Y
    Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.
    N Engl J Med. 2021;384:581-583.
    PubMed    
    
    
    December 2020
20. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2020;383:2652-2664.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.